Skip to main content
. 2022 Aug 10;31(165):220036. doi: 10.1183/16000617.0036-2022

FIGURE 3.

FIGURE 3

Forest plot for dichotomous outcomes. The vertical line indicates any effect. Figure 4 presents data in absolute effects with minimally important difference thresholds and Grades of Recommendation, Assessment, Development, and Evaluation ratings. ERA: endothelin receptor antagonist; PDE5i: phosphodiesterase-5 inhibitor; PRA: prostacyclin receptor agonist; inh: inhalation; i.v.: intravenous.